JANUS HENDERSON GROUP PLC Neurocrine Biosciences, Inc. Transaction History

JANUS HENDERSON GROUP PLC portfolio value:

$523.27M
portfolio value

JANUS HENDERSON GROUP PLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.50% -286.9K shares 15.03M $106.21 4.92M
Q2 2022 share Decrease -17.37% -1.09M shares -83.31M $97.48 5.21M
Q1 2022 share Decrease -15.26% -1.13M shares -42.61M $93.75 6.30M
Q4 2021 share Decrease -17.14% -1.54M shares -227.70M $84.63 7.44M
Q3 2021 share Increase +0.38% 34.23K shares -9.34M $95.91 8.98M
Q2 2021 share Decrease -3.02% -279.21K shares -26.53M $97.32 8.95M
Q1 2021 share Increase +0.77% 70.14K shares 19.64M $97.25 9.23M
Q4 2020 share Increase +39.90% 2.61M shares 248.39M $95.85 9.16M
Q3 2020 share Increase +0.83% 54.20K shares -162.59M $96.16 6.54M
Q2 2020 share Decrease -14.88% -1.13M shares 131.98M $122 6.49M
Q1 2020 share Increase +3.47% 255.68K shares -132.27M $86.55 7.62M
Q4 2019 share Decrease -13.29% -1.13M shares 26.32M $107.49 7.37M
Q3 2019 share Decrease -9.07% -848.70K shares -23.35M $90.11 8.50M
Q2 2019 share Increase +6.13% 540.27K shares 13.27M $84.43 9.35M
Q1 2019 share Increase +0.05% 4.54K shares 147.39M $88.1 8.81M
Q4 2018 share Increase +22.97% 1.64M shares -251.68M $71.41 8.80M
Q3 2018 share Decrease -3.40% -252.39K shares 152.18M $122.95 7.16M
Q2 2018 share Decrease -0.66% -49.13K shares 109.44M $98.24 7.41M
Q1 2018 share Increase +29.31% 1.69M shares 171.13M $82.93 7.46M
Q4 2017 share Increase +4.80% 264.34K shares 110.34M $77.59 5.77M
Q3 2017 share Increase +2.62% 140.63K shares 90.62M $61.28 5.50M
Q2 2017 share Increase 0.00% 5.36M shares 246.88M $46 5.36M